Skip to content
AlternativeMed

VITAMINS & SUPPLEMENTS · GUIDE

Omega-3, Memory and Dementia: What Trials and Cohort Studies Found

Trials of omega-3 supplements for memory, thinking and dementia mostly found no benefit, while eating fish is linked to lower risk in cohort studies. See which groups were studied and what is uncertain.

Content last updated . This page has not been medically reviewed.

Back to Omega Fatty Acids Explained: Omega-3, Omega-6 and Omega-9
Quick answer
Randomized trials of omega-3 supplements in older adults, in people with memory complaints and in people with Alzheimer's disease have mostly not shown better memory or thinking than placebo. Studies that follow people who eat more fish over the years often find a lower risk of dementia, but those studies cannot show that the fish, or the omega-3 in it, was the cause. [1][2][3][4]

Three groups, kept separate

Results do not transfer between groups, so the table below separates them. "Omega-3" here means EPA and DHA from fish oil or algal oil unless stated; these are different from eating fish or from plant omega-3 (ALA).
4 findings · 1 mixed · 3 limited or unclearThe colour follows the evidence label on each card.

  1. Cognitively healthy adults aged 60 and over

    No good evidence of benefit

    A 2012 Cochrane review of 3 trials (placebo oils were olive or sunflower oil; one trial used margarine) found no benefit on cognitive tests, and none of the trials measured new dementia [1]. In VITAL, 1 g a day of marine omega-3 (840 mg EPA plus DHA) for about 2 to 3 years in people aged 60+ had no significant effect on cognitive change [2]

  2. Adults 40 and over without dementia, all trial types

    Mixed, promising but limited

    A 2024 dose-response meta-analysis of 24 studies (9,660 people, 3 to 36 months) reported an upward trend in executive function in the first 12 months, mainly above 500 mg a day of omega-3 and up to 420 mg of EPA, and more clearly where blood DHA plus EPA was not very low [5]. A 2025 overview of systematic reviews pooled a statistically significant but modest MMSE change (effect size 0.16, 95% CI 0.01 to 0.32) [6]

  3. Memory complaints or mild cognitive impairment (MCI)

    No good evidence of benefit

    MAPT gave people aged 70+ with memory complaints 800 mg DHA plus 225 mg EPA a day for 3 years: no significant difference from placebo [7]. A 12-month New Zealand trial in 60 adults with MCI (1,491 mg DHA plus 351 mg EPA a day) found no treatment effect on cognitive measures [8]

  4. Diagnosed Alzheimer's disease

    No good evidence of benefit

    A 2016 Cochrane review of 3 placebo-controlled trials (632 people with mild to moderate Alzheimer's) found no convincing evidence of benefit [3]. One of them gave 2 g a day of algal DHA for 18 months and found no slowing of cognitive or functional decline or of brain shrinkage [9]

The 2024 meta-analysis and the earlier trials point in different directions. The meta-analysis pooled many small, short studies that differed in product, amount and tests, and its authors describe the benefit as potential. [5] Our reading is that the question of executive function in people with already-adequate omega-3 status is open, not settled. See why omega-3 trials disagree.

Eating fish: what cohort studies show

A 2023 meta-analysis of 33 prospective cohort studies found that people who ate more fish had a lower risk of dementia (relative risk 0.84, 95% CI 0.75 to 0.93) and Alzheimer's disease (0.75, 0.57 to 0.97), and the authors called for randomized trials to confirm it. [4] In an autopsy study of 286 older adults, eating seafood at least once a week went with less Alzheimer's brain pathology, but only in people carrying the APOE e4 gene variant; fish oil supplement use was not significantly linked to any marker, and higher brain mercury was not linked to more pathology. [10] In the Framingham cohort, people whose red blood cell DHA was in the lowest quarter had smaller brain volumes and lower scores on some tests at one point in time. [11] These are associations: people who eat fish also differ in other ways. NCCIH notes a 2017 review suggesting that carriers of APOE4 might benefit from DHA before signs of Alzheimer's appear, which is a hypothesis, not an established effect. [12]

Proper evidence not found: a long randomized trial showing that an omega-3 supplement prevents dementia. We looked in PubMed and in Cochrane reviews; the 2012 review itself said direct evidence on new dementia was lacking. [1]

Frequently asked questions

Does fish oil prevent dementia?

Proper evidence not found. Trials in older adults found no benefit on memory tests, and no trial showed fewer dementia cases. [1][2]

Does omega-3 help people who already have Alzheimer's disease?

A Cochrane review of three placebo-controlled trials found no convincing evidence of benefit in mild to moderate Alzheimer's. [3]

Why do studies of people who eat fish look better than supplement trials?

Cohort studies show associations and cannot rule out other differences between fish eaters and others, while trials test one product against placebo. [4][2]

Is DHA or EPA better for memory?

Not established. The 2024 meta-analysis reported its main signal for EPA-containing amounts, but its authors call the benefit potential. [5]

Should I take omega-3 if I have a memory complaint?

Talk to a clinician first. Memory changes have many causes, and a trial in people with memory complaints found no benefit over 3 years. [7]

More details: evidence, limits and cautions

The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.

How to read the evidence labels

Labels used on this page: mixed, promising but limited, insufficient evidence, no good evidence of benefit, and Proper evidence not found (we looked and found nothing usable). Study amounts are study amounts, not advice. This page is information only: memory problems have many causes, some of them treatable, so a new or worsening change in memory is a reason to see a clinician, not to start a supplement.

Safety and who should ask first
In the trials above, the main side effect was mild stomach upset, and serious events did not differ from placebo in MAPT. [1][7] Prescribing information for a prescription omega-3 medicine notes some studies showed longer bleeding time and advises monitoring when it is combined with blood thinners or antiplatelet medicines. [13] Many older adults take such medicines, so ask a pharmacist before adding fish oil, and tell the surgical team about any omega-3 product before an operation. See fish oil, blood thinners and bleeding risk, medication interactions and quality testing and certifications. People with a fish or shellfish allergy should read fish and shellfish allergy and omega-3 products.

For other memory supplements see nootropic evidence by outcome and, for everyday causes of memory trouble, focus and memory research and evidence and omega-3 for older adults.

References
  1. Sydenham E et al. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 2012. Read 2026-10-23.
  2. Kang JH et al. Marine n-3 fatty acids and cognitive change among older adults in the VITAL randomized trial. Alzheimers Dement (N Y) 2022. Read 2026-10-23.
  3. Burckhardt M et al. Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst Rev 2016. Read 2026-10-23.
  4. Talebi S et al. Association between animal protein sources and risk of neurodegenerative diseases: a systematic review and dose-response meta-analysis. Nutr Rev 2023. Read 2026-10-23.
  5. Suh SW et al. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis. BMC Med 2024. Read 2026-10-23.
  6. Barros MI et al. Omega-3 Polyunsaturated Fatty Acids and Cognitive Decline in Adults with Non-Dementia or Mild Cognitive Impairment: An Overview of Systematic Reviews. Nutrients 2025. Read 2026-10-23.
  7. Andrieu S et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol 2017. Read 2026-10-23.
  8. Mengelberg A et al. The effects of docosahexaenoic acid supplementation on cognition and well-being in mild cognitive impairment: A 12-month randomised controlled trial. Int J Geriatr Psychiatry 2022. Read 2026-10-23.
  9. Quinn JF et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010. Read 2026-10-23.
  10. Morris MC et al. Association of Seafood Consumption, Brain Mercury Level, and APOE ε4 Status With Brain Neuropathology in Older Adults. JAMA 2016. Read 2026-10-23.
  11. Tan ZS et al. Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. Neurology 2012. Read 2026-10-23.
  12. NCCIH. Omega-3 Supplements: What You Need To Know. Read 2026-10-23.
  13. DailyMed (US National Library of Medicine). Prescribing information for a prescription icosapent ethyl medicine. Read 2026-10-23.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.